— Know what they know.
Not Investment Advice
Also trades as: 0I3I.L (LSE) · $vol 0M

COO NASDAQ

The Cooper Companies, Inc.
1W: +1.3% 1M: +5.8% 3M: -18.0% YTD: -26.2% 1Y: -18.5% 3Y: -26.2% 5Y: -40.4%
$59.88
-1.26 (-2.06%)
Pre-Market: $60.71 (+0.83, +1.39%)
Weekly Expected Move ±4.2%
$56 $59 $61 $64 $66
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 75 · $11.4B mcap · 189M float · 1.66% daily turnover · Short 30% of daily vol
Credit Risk of going bust: lower than 68% of companies Debt: 18.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.11 (down 98%), The Cooper Companies, Inc. would be worth roughly what it owes.
Total debt $2.54B against a stock market value of $11.39B.
Distance to default 7.35 (Merton model): prices to 2026-10-27, balance sheet 2026-07-31, debt counted $1.59B (short-term plus half of long-term), stock volatility 32.4%; Altman Z 2.98. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

10 relationships
10
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2021-11-10
Earliest Filing
2026-02-04
Latest Filing
target: 5 partner: 2 customer: 1 acquirer: 1 investor: 1

Counterparties (Filed by COO)

10 relationships

Companies named in COO's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
CooperVision International Limited — customer Co-borrower alongside the Company for the Revolving Credit Agreement. 2026-02-04 View
Browning West, LP — partner Entered into a letter agreement to appoint a director and establish board cooperation terms. 2025-12-23 View
Cook Medical Holdings LLC — target Target of asset purchase for Reproductive Health business 2022-02-07 View
Cook Medical — target Parent entity of the business assets being acquired 2022-02-07 View
GI Generate Parent LLC — target Target company acquired in the merger 2021-12-17 View
GI Partners Acquisitions LLC — partner Party to the Merger Agreement 2021-12-17 View
CooperSurgical, Inc. COO target Wholly owned subsidiary of The Cooper Companies, Inc. entering merger agreement. 2021-11-10 View
Bruin Merger Sub, LLC — acquirer Direct, wholly owned subsidiary of CooperSurgical, Inc. merging with Generate. 2021-11-10 View
GI Generate Parent LLC — target Parent entity of Generate Life Sciences being acquired by CooperSurgical. 2021-11-10 View
GI Partners Acquisitions LLC — investor Entity involved in the Merger Agreement alongside Generate. 2021-11-10 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-27 Officer/Director Change; Regulation FD; Exhibits View
2026-09-09 Earnings Release; Other Events; Exhibits View
2026-06-04 Earnings Release; Other Events; Exhibits View
2026-05-04 Officer/Director Change View
2026-04-08 Shareholder Vote View
2026-03-05 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-02-04 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-12-23 Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; Agreement View
2025-12-12 Departure/Election of Directors; Appointment of Officers View
2025-12-04 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2025-08-27 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-05-29 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-30 Departure/Election of Directors; Appointment of Officers View
2025-04-02 Submission of Matters to a Vote of Security Holders View
2025-03-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-02-05 Departure/Election of Directors; Appointment of Officers View
2024-12-05 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-10-25 Amendments to Articles of Incorporation or Bylaws View
2024-08-28 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-05-30 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms